Merck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease

Press/Media: Press / Media

PeriodApr 24 2015 → Apr 25 2015

Media coverage

65

Media coverage

  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletRed Orbit
    CountryUnited States
    Date4/25/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletMorningstar.com
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletFinancial Content
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletSearchBug
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletIndustrial Info Financials
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletTown Hall
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletBioSpace
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletRCL Advisors
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletFranklin Credit Management Corporation
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletReliance Trust
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletMarket Pulse Navigator
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletWorldNetDaily
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletMarketplace
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletFat Pitch Financials
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletCrawford Financial Planning
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletCEOWorld Magazine
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletWall Street Business Network
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletFinancial Content
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletTickerTech.com
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletTamar Securities
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational
    Media name/outletFinwin
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletTradingCharts.com
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletGood Day Sacramento
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletStock Nod
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletAsk.com
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletKiiiTV3.com
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletKATV
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletCW Richmond WUPV
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletKMEG 14
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletMyFoxTallahassee.com
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletFOX 14 TV
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletKTUL
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletKXNet.com
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletKAUZ
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletKSWO
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outlet35 WSEE
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletKCEN HD
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletKMPH Fox 26
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletNebraska TV
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletKYTX CBS 19
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outlet12 News Now
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletKuam News 8
    CountryGuam
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletGTN News
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletKFMB-TV
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletNews 9
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletABC News 4 Charleston
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletFox41.com
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletWCAX TV3
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletKPTM FOX 42
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletWBOY
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletWBOC TV 16
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletKUSI.com
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletKRHD TV
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletKPLC TV
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletWVNS
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletWXTX Fox 54
    CountryGeorgia
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletWSET
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletWLTZ 38
    CountryGeorgia
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletAZ-TV7
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletWAND TV
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletKNDO KNDU
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletABC 3340
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletWTRF
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletKSTC-TV
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz
  • TitleMerck Announces Results from C-SURFER Phase 2/3 Study of Investigational Chronic Hepatitis C Therapy Grazoprevir/Elbasvir in Patients with Advanced Chronic Kidney Disease
    Media name/outletWSFX-TV
    CountryUnited States
    Date4/24/15
    PersonsEric J Lawitz